Search alternatives:
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
381
Fig 18 in each curve fitting results.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
382
Fig 29 in each curve fitting results.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
383
Fig 9(b) in the straight-line fitting results.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
384
Specimen packaging process.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
385
Relationship between τ<sub><i>i</i></sub> and σ<sub><i>i</i></sub>.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
386
The relationship between Δσ<sub>n</sub> and τ<sub>1</sub>, <i>JRC</i>.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
387
Relationship between τ<sub><i>i</i></sub> and σ<sub><i>i</i></sub>.
Published 2024“…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …”
-
388
-
389
-
390
-
391
Flowchart of the screening process.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
392
Result of the AMSTAR-2 assessments.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
393
Characteristics of included reviews.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
394
Result of the PRISMA assessments.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
395
Result of the ROBIS assessments.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
396
Cohort characteristics.
Published 2025“…</p><p>Results</p><p>Upon initiation of CPB we observed a significant decrease in arterial whole blood redox potential (101.90 mV + /- 11.52 vs. 41.80 mV + /- 10,26; p < 0.0001). …”
-
397
Study selection criteria.
Published 2025“…</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”
-
398
PICOS criteria for the SLR.
Published 2025“…</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”
-
399
PRISMA flow chart.
Published 2025“…</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …”
-
400
Analytical framework and statistical methods.
Published 2024“…Our findings reveal significant variations in income insecurity and social protection responses across these groups. the pandemic had a significant impact on household incomes globally, with lower-middle-income countries experiencing the most significant income reductions. …”